2026 NPPES data Radiation Oncology Physician NPI 1801930441 MD
Verify on CMS →

ALIREZA MIRMIRAN, MD

Radiation Oncology Physician in OMAHA, Nebraska. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
236
Medicare Part D claims · 65 beneficiaries · Radiation Oncology Physician avg: 186
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$149.32
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ALIREZA MIRMIRAN, MD filed 236 Medicare Part D claims in 2023 as a Radiation Oncology Physician in OMAHA, Nebraska, prescribing 90% generic.

236
Part D claims, 2023
90%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALIREZA MIRMIRAN, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

236 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

ALIREZA MIRMIRAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ALIREZA MIRMIRAN, MD?

Quality data not reported

NPI registry status

Active

Issued 02/16/2007

NPI 1801930441

Primary specialty

Radiation Oncology Physician

Mid-sized

6,018 US NPIs in this specialty

Medicare Part D claims

236 27% vs specialty avg

2023 prescription claims

Specialty avg: 186

Specialty distribution in Nebraska

How Radiation Oncology Physician compares to other specialties among Nebraska providers

Nebraska providers

Radiation Oncology Physician share within Nebraska

1. Radiation Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Radiation Oncology Physician share within Nebraska

Specialty board-certification context

Estimated specialty board-certified rate — Radiation Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Radiation Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Radiation Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Radiation Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALIREZA MIRMIRAN, MD appears in the CMS NPPES registry as a Radiation Oncology Physician provider holding MD credentials at 8303 DODGE ST, OMAHA, NE, 68114, with a listed phone of (402) 354-4104. NPI 1801930441 was issued on 02/16/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MIRMIRAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 236 prescription claims written by this provider, covering 65 Medicare beneficiaries and totaling roughly $7K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Radiation Oncology Physician is a mid-sized specialty nationwide, with 6,018 enrolled providers across 52 states and an average of 186 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8303 DODGE ST
OMAHA, NE 68114

Provider Details

NPI 1801930441
Specialty Radiation Oncology Physician
Credentials MD
Gender Male
NPI Issued 02/16/2007

Hospital and facility affiliations

Facilities where ALIREZA MIRMIRAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NEBRASKA METHODIST HOSPITAL
COUNCIL BLUFFS, IA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALIREZA MIRMIRAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$149

Largest payer

Novocure Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

ALIREZA MIRMIRAN, MD — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 236 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

236
Total Claims
$7K
Total Drug Cost
65
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
280
Total Day Supply
6,887
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$3K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
74.5 years
Avg HCC Risk Score
1.86
Gender Split
46% female / 54% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ALIREZA MIRMIRAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Tamsulosin Hcl
57
Venlafaxine Hcl Er
Venlafaxine Hcl
19
Lidocaine Hcl Viscous
Lidocaine Hcl
18
Trazodone Hcl
13
Venlafaxine Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Radiation Oncology Physician Overview

How ALIREZA MIRMIRAN, MD fits within the Radiation Oncology Physician landscape nationally.

6,018
Radiation Oncology Physician Providers in US
52
States with Radiation Oncology Physician
186
Avg Claims per Provider

ALIREZA MIRMIRAN, MD's 236 claims are above the specialty average of 186.

Nearby Radiation Oncology Physician Providers in Nebraska

Other clinicians with the same primary specialty enrolled in Nebraska, drawn from the same CMS NPPES roster as MIRMIRAN.

Compare Radiation Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALIREZA MIRMIRAN, MD's specialty?
ALIREZA MIRMIRAN, MD specializes in Radiation Oncology Physician and practices in OMAHA, Nebraska. Credentials: MD.
How much does ALIREZA MIRMIRAN, MD prescribe under Medicare Part D?
In 2023, ALIREZA MIRMIRAN, MD wrote 236 Medicare Part D claims totaling $7K in drug costs for 65 beneficiaries.
Where is ALIREZA MIRMIRAN, MD located?
ALIREZA MIRMIRAN, MD is located at 8303 DODGE ST, OMAHA, NE, 68114. Phone: (402) 354-4104.
What is ALIREZA MIRMIRAN, MD's NPI number?
ALIREZA MIRMIRAN, MD's National Provider Identifier (NPI) is 1801930441, issued on 02/16/2007.
Does ALIREZA MIRMIRAN, MD prescribe more brand-name or generic drugs?
ALIREZA MIRMIRAN, MD's prescribing is 10% brand-name and 90% generic drugs by claim count, with $3K in brand drug costs.
How many Radiation Oncology Physician providers are there in the US?
There are 6,018 Radiation Oncology Physician providers across 52 states in the US. The average Radiation Oncology Physician provider writes 186 Medicare Part D claims per year.
What drugs does ALIREZA MIRMIRAN, MD prescribe most often?
Based on 2023 Medicare Part D data, ALIREZA MIRMIRAN, MD's most frequently prescribed drugs include Tamsulosin Hcl, Venlafaxine Hcl Er, Lidocaine Hcl Viscous. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALIREZA MIRMIRAN, MD accept Medicare?
ALIREZA MIRMIRAN, MD appears in CMS Medicare data with 236 Part D claims and 65 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALIREZA MIRMIRAN, MD's credentials?
ALIREZA MIRMIRAN, MD's NPI is 1801930441 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology